Cargando…

Role of PLK1 signaling pathway genes in gastrointestinal stromal tumors

In previous studies by the authors, aurora kinase A (AURKA) was demonstrated as an independent poor prognostic marker for the recurrence of localized gastrointestinal stromal tumors (GISTs) and for the progression of advanced GISTs. In the present study, the prognostic effect of genes involved in ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jen-Shi, Yeh, Chun-Nan, Cheng, Chi-Tung, Yen, Chueh-Chuan, Chen, Yen-Yang, Huang, Shih-Chiang, Chiang, Kun-Chun, Yeh, Ta-Sen, Chen, San-Chi, Chao, Ta-Chung, Yang, Muh-Hwa, Chao, Yee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096274/ https://www.ncbi.nlm.nih.gov/pubmed/30127898 http://dx.doi.org/10.3892/ol.2018.9003

Ejemplares similares

Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study()
por: Chen, Yen-Yang, et al.
Publicado: (2014)

Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
por: Chang, Shih-Chun, et al.
Publicado: (2016)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
por: Wang, Shang-Yu, et al.
Publicado: (2019)

Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study
por: Hu, Chia-Hsiang, et al.
Publicado: (2020)

Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2015)

Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong Experience
por: Lin, Li-Ching, et al.
Publicado: (2022)

A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17
por: Yeh, Chun-Nan, et al.
Publicado: (2017)

Corrigendum: Compassionate use of ripretinib for patients with metastatic gastrointestinal stromal tumors: Taiwan and Hong Kong experience
por: Lin, Li-Ching, et al.
Publicado: (2022)

Prediction of Gastric Gastrointestinal Stromal Tumors before Operation: A Retrospective Analysis of Gastric Subepithelial Tumors
por: Lin, Yu-Ning, et al.
Publicado: (2022)

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015)

Autophagy is involved in endogenous and NVP-AUY922-induced KIT degradation in gastrointestinal stromal tumors
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2013)

Non‐small cell lung cancer with gastric metastasis and repeated gastrointestinal bleeding: A rare case report and literature review
por: Shih‐Chun, Chang, et al.
Publicado: (2021)

Cytoreductive Surgery may be beneficial for highly selected patients with Metastatic Gastrointestinal Stromal Tumors receiving Regorafenib facing Local Progression: A Case Controlled Study
por: Yeh, Chun-Nan, et al.
Publicado: (2021)

Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma
por: Chen, Ming-Huang, et al.
Publicado: (2014)

The clinicopathological significance of SWI/SNF alterations in gastric cancer is associated with the molecular subtypes
por: Huang, Shih-Chiang, et al.
Publicado: (2021)

Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2014)

Targeted ultra-deep sequencing unveils a lack of driver-gene mutations linking non-hereditary gastrointestinal stromal tumors and highly prevalent second primary malignancies: random or nonrandom, that is the question
por: Lai, Bo-Ru, et al.
Publicado: (2016)

HO-1 is a favorable prognostic factor for HBV-HCC patients who underwent hepatectomy
por: Yeh, Chun-Nan, et al.
Publicado: (2018)

MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2014)

Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
por: Chiang, Kun-Chun, et al.
Publicado: (2019)

Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

Systemic Therapy for Gastrointestinal Stromal Tumor: Current Standards and Emerging Challenges
por: Huang, Wen-Kuan, et al.
Publicado: (2022)

Selecting Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor with Secondary KIT Activation-Loop Domain Mutations
por: Hsueh, Yuan-Shuo, et al.
Publicado: (2013)

Chemopreventive and chemotherapeutic effects of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model
por: Chiang, Kun-Chun, et al.
Publicado: (2014)

Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study
por: Hsu, Jun-Te, et al.
Publicado: (2017)

WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer
por: Chiang, Kun-Chun, et al.
Publicado: (2015)

Risk of Stroke and Post-Stroke Adverse Events in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease
por: Lin, Chao-Shun, et al.
Publicado: (2017)

A Single-Cell Level and Connectome-Derived Computational Model of the Drosophila Brain
por: Huang, Yu-Chi, et al.
Publicado: (2019)

Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
por: Chiang, Kun-Chun, et al.
Publicado: (2012)

N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer: A Modified System Based on Current AJCC Staging
por: Yeh, Chun-Nan, et al.
Publicado: (2015)

Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer
por: Hsu, Jun-Te, et al.
Publicado: (2015)

Aspartate and Acetate Fuel Gastrointestinal Stromal Tumors Beyond the Warburg Effect
por: Lai, Ying-Chieh, et al.
Publicado: (2022)

Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study
por: Ke, Chi-Chen, et al.
Publicado: (2015)

Correction: Adverse Outcomes after Non-Chest Surgeries in Patients with Pulmonary Tuberculosis: A Nationwide Study
por: Ke, Chi-Chen, et al.
Publicado: (2017)

Clinical Characteristics of COVID-19 Patients and Application to an Artificial Intelligence System for Disease Surveillance
por: Wang, Ying-Chuan, et al.
Publicado: (2022)

Driving Cells to the Desired State in a Bimodal Distribution through Manipulation of Internal Noise with Biologically Practicable Approaches
por: Shu, Che-Chi, et al.
Publicado: (2016)

Inhibitors Alter the Stochasticity of Regulatory Proteins to Force Cells to Switch to the Other State in the Bistable System
por: Jhang, Wun-Sin, et al.
Publicado: (2017)

Impact of Overlapping Functional Gastrointestinal Disorders on the Presentation and Quality of Life of Patients with Erosive Esophagitis and Nonerosive Reflux Disease
por: Lee, Shou-Wu, et al.
Publicado: (2015)

Corticosteroid-Induced Liver Injury in Adult-Onset Still’s Disease
por: Lee, Chin-Chi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tcf6cuu4cl8csdv6u9d9im6nhs